| Name | Title | Contact Details |
|---|---|---|
Nadder Sahar |
Sr. Director, Data Science | Profile |
Tim Van Ryzin |
Director, Cybersecurity and Compliance | Profile |
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany.
Abingdon Health Care LLC in Abingdon, VA, is rated 2.9 stars overall. It is a moderate facility with 120 beds and has for-profit, corporate ownership. Abingdon Health Care LLC is not part of a continuing care retirement community. It participates in Medicare and Medicaid.
Quality Assured Services, Inc. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Liberty Medical Supply is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Based at NASA-Ames Research Center, Scanadu is using mobile and sensor technology to develop a portfolio of FDA approved, consumer friendly products that put the experience of an emergency room in the palm of your hand. Unveiled in November 2012, the company is working to ensure this is the last generation to know so little about our health. The product portfolio includes the Scanadu Scout vital sign monitor and Scanadu Urine, a urine analysis test. In July 2013, Scanadu became the most funded campaign on Indiegogo, enlisting supporters to be a part of the first usability study, followed by clinical studies for the company’s road to FDA approval.